This trial is testing whether a new approach to managing low back pain will decrease healthcare resource utilization and improve quality of life.
1 Primary · 2 Secondary · Reporting Duration: Through study completion, an average of 30 months
Active Control
Experimental Treatment
240 Total Participants · 2 Treatment Groups
Primary Treatment: ABCp · No Placebo Group · Phase 2
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:18 - 65 | 100.0% |
University of Alberta | 100.0% |
Met criteria | 100.0% |